NATICK, Mass., Oct. 3 /PRNewswire-FirstCall/ -- Boston Scientific Corporation announced today the grand opening of its new Maple Grove, Minnesota Research and Development facility, which includes several research and development labs, the core Cardiovascular new Technology and Product Development organization and other supporting functions. Minnesota Lt. Governor Carol Molnau joined Boston Scientific employees for the ribbon cutting ceremony and open house.
"We are proud that Minnesota is home to Boston Scientific and other companies who are at the forefront of their industries and are significant drivers of economic growth," said Lieutenant Governor Carol Molnau. "Boston Scientific's innovations have improved the lives of countless patients worldwide while further establishing Minnesota as a global hub for the development and manufacture of medical devices."
The state-of-the-art 152,000 square foot facility will support more than 500 employees and will include an 11,000 square foot conference center. The facility is one of four buildings on the Company's Maple Grove campus, which employs approximately 3,000 people, 800 of whom support research and development activities. The facility is designed to be a high-performing, sustainable, and environmentally responsible building.
"Boston Scientific is committed to investing in the research and development that will lead to the innovations of tomorrow," said Fred Colen, Executive Vice President and Chief Technology Officer at Boston Scientific. "This new first-class facility for our first-class Cardiovascular R&D organization is a result of the tremendous growth we have experienced as a company and will help us to deliver again what's next to our customers and their patients."
Boston Scientific's Maple Grove and Plymouth campuses are focused on technologies and products used to diagnose and treat cardiovascular disease and other cardiovascular disorders, peripheral vascular disease and vascular disease.
Joining Lt. Governor Molnau for the opening ceremonies were Maple Grove Mayor Mark Steffenson, City of Maple Grove City Council member Karen Jaeger and Minnesota Department of Economic Development representative Patti Neuman.
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com/.
This press release contains forward-looking statements. Boston Scientific wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with new product development and commercialization, intellectual property, regulatory approvals, Boston Scientific's overall business strategy, and other factors described in Boston Scientific's filings with the Securities and Exchange Commission.
CONTACT: Milan Kofol
508-650-8569
Investor Relations
Boston Scientific Corporation
Paul Donovan
508-650-8541
Media Relations
Boston Scientific Corporation
